Purpose: Health applications are employed to aid patients with chronic diseases in effective long-term disease management. This investigation aims to measure the utilization of health applications among patients diagnosed with chronic conditions during the COVID-19 pandemic. Methods: This cross-sectional investigation was conducted in the Jazan region in Saudi Arabia between October 2020 and March 2021. Data were collected during interviews using a semi-structured questionnaire. The questionnaire collected items about the patients' demographics, morbidity, and use of electronic devices and health applications developed by the Saudi MoH. Logistic regression was used to assess factors associated with odds of reporting use of applications. Results: A total of 658 patients were recruited. The mean age of the patients was 51 years, and 59% of them were females. The most frequently reported diagnosed condition was diabetes (53.5%), followed by hypertension (42.7%). Majority of the patients reported not using any health applications developed by the Saudi MoH (68.2%). Patients with higher educational levels and younger patients were more likely to report use of the applications (ORs: 4.2, 2.6 respectively). Comorbidity history and disease duration did not seem to influence the probability of reporting use of health applications (P-values >0.05). Conclusion:Patients diagnosed with chronic diseases in Jazan had low utilization of health applications developed by the Saudi MoH. This indicates a need to encourage the use of these health applications, particularly among patients with chronic diseases and to consider use restriction among older patients with lower educational levels.
Sudden prevalence of coronavirus disease-2019 (COVID-19) has badly impeded and collapsed the emerging global trend of economic development by its ongoing pandemic. The novel coronavirus also named severe acute respiratory syndrome virus – 2 (SARS-CoV-2) causes the disease COVID-19 that influences the health management of humans and the world commerce badly. It has affected the human social lives and education in underdeveloped countries and severely impeded industries, organizations, agriculture, etc. Three perceptible types of SARS-CoV-2 strains have been discovered. Each of them has specific receptors, and some of them are common in SARS and SARS-CoV-2. Among them, the ACE2 receptor is believed to be the central receptor of human infectious coronaviruses. It supports mainly to get access, enter into the cell, and causes the basic infection. Similarly, TMPRSS2 is also acting as a portal for a virus to get an approach to the cell and does not support metabolic processes like replication virus. ADAM17, which is a member of disintegrins and metalloproteases and is responsible for cell to cell and cell-array interconnections. These receptors can be important for prevention, vaccine development, and therapies. Several therapies in SARS-CoV-2 infected patients have been tried and suggested. Plasma and stem cell therapy reduce the severity of infection at certain levels in individual patients. In this review, we make an effort to cover all of the said aspects of COVID-19 in a very compressive and brief way. Finally, we shed light on vaccination and therapeutic approaches like plasma therapy and stem therapy and their future perspective with the whole discussion conclusion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.